HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS

The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

Saved in:
Bibliographic Details
Main Authors GORDON THOMAS D, HAYES MARTIN E, HOEMANN MICHAEL Z, IHLE DAVID C, LO SCHIAVO GLORIA Y, FRIEDMAN MICHAEL, LI BIN, CUSACK KEVIN P, SOMAL GAGANDEEP K, BAKKER WOUTER IWEMA
Format Patent
LanguageEnglish
Published 26.06.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Abstract The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
AbstractList The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Author LI BIN
HOEMANN MICHAEL Z
CUSACK KEVIN P
FRIEDMAN MICHAEL
SOMAL GAGANDEEP K
HAYES MARTIN E
BAKKER WOUTER IWEMA
GORDON THOMAS D
LO SCHIAVO GLORIA Y
IHLE DAVID C
Author_xml – fullname: GORDON THOMAS D
– fullname: HAYES MARTIN E
– fullname: HOEMANN MICHAEL Z
– fullname: IHLE DAVID C
– fullname: LO SCHIAVO GLORIA Y
– fullname: FRIEDMAN MICHAEL
– fullname: LI BIN
– fullname: CUSACK KEVIN P
– fullname: SOMAL GAGANDEEP K
– fullname: BAKKER WOUTER IWEMA
BookMark eNrjYmDJy89L5WQw8HANcQ3yd4509vF0VvALdfZxdQxS8PAP8vX3c1UIcnV2DQjxD1Lw9XcJ9XEEsoJ5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8aLCRgaGJobmlmbmZo6ExcaoA8LIpbQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2014179676A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2014179676A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:01:48 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2014179676A13
Notes Application Number: US201314135793
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140626&DB=EPODOC&CC=US&NR=2014179676A1
ParticipantIDs epo_espacenet_US2014179676A1
PublicationCentury 2000
PublicationDate 20140626
PublicationDateYYYYMMDD 2014-06-26
PublicationDate_xml – month: 06
  year: 2014
  text: 20140626
  day: 26
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies LI BIN
HOEMANN MICHAEL Z
ABBVIE INC
CUSACK KEVIN P
FRIEDMAN MICHAEL
SOMAL GAGANDEEP K
HAYES MARTIN E
BAKKER WOUTER IWEMA
GORDON THOMAS D
LO SCHIAVO GLORIA Y
IHLE DAVID C
RelatedCompanies_xml – name: FRIEDMAN MICHAEL
– name: IHLE DAVID C
– name: LI BIN
– name: BAKKER WOUTER IWEMA
– name: ABBVIE INC
– name: SOMAL GAGANDEEP K
– name: GORDON THOMAS D
– name: LO SCHIAVO GLORIA Y
– name: HAYES MARTIN E
– name: CUSACK KEVIN P
– name: HOEMANN MICHAEL Z
Score 2.9394143
Snippet The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140626&DB=EPODOC&locale=&CC=US&NR=2014179676A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlILSt-JcP9KXIl2aUWVbS7vKfBpJ28BAuuEq_vtew6Z72luSg3yRX-53yV0C8Fg8C6sgQhhS8r6B_L80eG5JA3WVSThxRSmVl-_ECTPrbWbPWvC5jYVR74T-qMcREVE54r1W-_Xq_xArUL6V6yexwKLly3DqBfrGOkZrAQm6Hgw8FkdBRHVKvSzVJ4mS4dpziOOjrXSARJo0eGDvgyYuZbWrVIancBhjfVV9Bq2y6sAx3f691oGj8ebKG5Mb9K3PoRcyJJ8R_aCjV6pNMjpifqKFUYL7ItMSRlk8jRJtHAXZyMdUegEPQzaloYFNz_9GOs_S3X6al9CullV5BRoXhOTcFoWN9lJeWlyaksteT7pIjm3HvYbuvppu9otv4aTJNh5QfacL7frru7xDXVuLezVFv28gfqM
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXp1ILSt-Lc2mYvQ7o0pdOuHV0r82kkXQOCdMNV_Pe9hk33tLeQg8sHubvfJXcXgIfFkzAXRAhDSt41EP_nBs9MaaCt6hFO-iKXKso3tP3UfJlZsxp8bnNhVJ3QH1UcESUqQ3kvlb5e_V9iuSq2cv0oPrBr-ewlA1ffeMfoLSBA193hgE0iN6I6pYN0qoexouHZs4ntoK90gCCbVPLA3oZVXspq16h4J3A4QX5FeQq1vGhCg27_XmvC0Xjz5I3NjfStz6DjMwSfEX2nwYhqYUoD5sSaH8WoF5kWM8omSRRr48hNAwdb03O491hCfQOHnv-tdJ5Od-fZu4B6sSzyS9C4ICTjllhY6C9lucllT3LZ6cg-gmPL7regvY_T1X7yHTT8ZBzMg1H4eg3HFamKhurabaiXX9_5DdrdUtyq7foFiquBlg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HETEROCYCLIC+NUCLEAR+HORMONE+RECEPTOR+MODULATORS&rft.inventor=GORDON+THOMAS+D&rft.inventor=HAYES+MARTIN+E&rft.inventor=HOEMANN+MICHAEL+Z&rft.inventor=IHLE+DAVID+C&rft.inventor=LO+SCHIAVO+GLORIA+Y&rft.inventor=FRIEDMAN+MICHAEL&rft.inventor=LI+BIN&rft.inventor=CUSACK+KEVIN+P&rft.inventor=SOMAL+GAGANDEEP+K&rft.inventor=BAKKER+WOUTER+IWEMA&rft.date=2014-06-26&rft.externalDBID=A1&rft.externalDocID=US2014179676A1